Supports investigator-led spinal cord injury research across basic to translational science phases. Aims to advance SCI patient care, treatment outcomes, and quality of life through competitive grants.
This DoD funding supports clinical trials testing new spinal cord injury treatments with potential to significantly improve patient outcomes. The program welcomes early-career researchers and requires community partnership to ensure research relevance.
This DoD funding supports early-stage lupus research planning, pilot studies, and phase 0/1 clinical trials to generate preliminary data and demonstrate feasibility for future interventional studies. Awards must include patient advocates and address FY26 lupus research priorities.
This DoD funding supports clinical translation research to move spinal cord injury treatments from preliminary studies into larger clinical trials. It prioritizes removing barriers to clinical success and identifying effective diagnosis, treatment, and rehabilitation options.
This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.
DoD seeks innovative, high-risk lupus research addressing critical gaps in disease understanding and treatment. Early-career researchers can propose novel ideas with or without preliminary data, emphasizing breakthrough discoveries over incremental advances.
Support innovative, high-risk MS research concepts at early exploration stages through hypothesis development. This award funds groundbreaking studies that establish foundations for future scientific investigation, with no preliminary data required.
This DoD funding supports high-risk, high-reward lupus research with potential for major scientific impact. Researchers can pursue innovative approaches addressing priority focus areas without requiring preliminary data.
Support early-stage researchers investigating Multiple Sclerosis through independent, mentor-guided projects. This award develops the next generation of MS researchers by funding novel research questions and advancing scientific careers in neuroimmunology.
DoD seeks interventional lupus research with near-term health impact, including clinical trials and health system innovations. Teams must include patient advocates and provide preliminary data demonstrating feasibility and potential quality-of-life improvements.
Support rigorous, investigator-initiated research projects advancing Multiple Sclerosis understanding and patient outcomes. Funding available for laboratory, clinical, and population-based studies with preliminary data, including dedicated tracks for early-career investigators.
The Army seeks clinical trial research to advance vision capabilities and treatments. This opportunity supports innovative medical studies addressing soldier visual performance and eye health.
Army seeks investigator-initiated research proposals addressing vision science and ocular performance challenges. Support ranges from basic science through applied research to advance soldier visual capabilities and medical treatments.
TechConnect seeks innovative technologies to identify, secure, and communicate hazardous energy risks in workplaces. Solutions should advance lockout/tagout capabilities to reduce worker injuries and fatalities across industries.
DOJ seeks rigorous research on how drug trafficking and firearms intersect to fuel violence. Projects should develop evidence-based tools and strategies for law enforcement to disrupt drug markets and prosecute related crimes.
Establish a breast cancer research consortium by bringing together investigators and patient advocates to develop preliminary research and framework. This development award prepares teams for a future full consortium competition addressing critical gaps in breast cancer science.
This DoD award funds multidisciplinary, multi-institutional consortia addressing transformative breast cancer research challenges. Led by up to five PIs and consumer advocates, projects must tackle major problems requiring collaborative breakthroughs that single investigators cannot achieve.
This pilot award funds innovative ovarian cancer research that challenges current thinking and explores novel concepts to drive breakthrough discoveries. Projects must demonstrate exceptional scientific merit and innovative approaches to advance the field.
Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.
Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.
This DoD program funds breakthrough breast cancer research addressing major scientific challenges with potential for clinical impact. Researchers can pursue Level 1 or 2 funding, partnering with co-investigators and population science studies to accelerate discoveries from bench to bedside.
DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.